Why the study?
To estimate the prevalence of HCM in neonates born to diabetic mothers, evaluate therapeutic interventions, and assess its association with maternal diabetes type.
What is the prevalence of hypertrophic cardiomyopathy in neonates of diabetic mothers, and is it associated with maternal diabetes control or type?
What is the prevalence of hypertrophic cardiomyopathy in neonates of diabetic mothers, and is it associated with maternal diabetes control or type?
Uncontrolled maternal diabetes is significantly associated with a 14% prevalence of hypertrophic cardiomyopathy in neonates, which can be effectively managed with propranolol.
Answers are grounded in this paper and cite their sources.
Neonatal HCM screening in diabetic pregnancies remains hypothesis-generating; leaves open optimal detection and maternal diabetes-type associations.
Background: Hypertrophic cardiomyopathy (HCM) is known to be the most common cardiac disorder in fetuses of diabetic mothers, especially when diabetes is not controlled in pregnancy. This study aimed as to estimate the prevalence of HCM in neonates born to diabetic mothers and to evaluate therapeutic interventions with follow-up after six months. We also focused on the possible association of neonatal HCM with the maternal type of diabetes. Methods: A cross-sectional study was conducted between October 2016, and September 2017, in the Cardiac Clinic of Yazd, a city in the center of Iran. The subjects were 150 neonates of mothers with diabetes. We determined HCM through fetal echocardiography before treatment and assessed the maternal and fetal factors. Finally, after a 6-month follow-up period, the data were analyzed statistically. Results: According to the results, the prevalence of HCM in neonates of diabetic mothers was 14% (P < 0.0001). The results showed that there is a relationship between maternal uncontrolled diabetes and the incidence of HCM in the infant (P < 0.0001), but there is no relationship between the type of diabetes and the incidence of HCM. Our results also showed that propranolol was effective in improving HCM, and spontaneous recovery of HCM was low in infants. Conclusion: We concluded that controlling maternal diabetes has the greatest effect on the prevention of HCM in neonates. Also, neonates of diabetic mothers need more heart tests and follow-ups. Therefore, more studies on the effects of maternal diabetes-induced HCM in neonates are needed.
No takes yet. Share an insight, caveat, or question.
Lookzadeh et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: